跳至主要内容
临床试验/NCT03372824
NCT03372824已完成不适用

Oral Glucose Tolerance Test (OGTT), HbA1c or Glycated Albumin - Can we Reduce the Need for OGTT in Pregnancy?

Helse Stavanger HF1 个研究点 分布在 1 个国家目标入组 148 人开始时间: 2017年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
148
试验地点
1
主要终点
Glycated albumin reference interval in pregnancy

研究概览

简要总结

This is an observational study at the Obstetrical outpatient clinic at Stavanger University Hospital, Norway. The purpose of the study is to compare glycated albumin and glycated hemoglobin (HbA1c), both markers of "long-term blood sugar" with oral glucose tolerance test (OGTT). The OGTT is a screening test for gestational diabetes, a condition that increases risk of adverse pregnancy outcome for mother and child. The risks are reduced with good glycaemic control throughout pregnancy, therefore, it is important to screen for gestational diabetes.

详细描述

According to the new guideline by the Norwegian Directorate of Health published april 2017, screening for gestational diabetes is increased. All pregnant women with a slight risk, approximately 70 % of pregnant women i Norway, should have an OGTT performed in gestational week 24-28. Among those women, all primiparas above the age of 25 years old.

The investigators will include 150 primiparas above the age of 25 years old in the study. The women will be asked to participate in the study when they attend an ultrasound examination at the Obstetric outpatient clinic in gestational week 18-20. Prior to inclusion, participants need to sign written informed consent.

Included women will get an appointment for OGTT in gestational week 24-28 at the Clinical trial unit, Stavanger University hospital. The OGTT will be performed according to national guidelines. The participants will fill in a single questionaire with information on age, height, ethnicity, whether there is diabetes in close family, any other illnesses, smoking habits and other medications/supplements.

In addition, to blood sugar levels, markers of importance for glycaemic control, iron status and vitamin-D status will be analyzed.

Women diagnosed with gestational diabetes or overt diabetes mellitus, will be followed up according to national guidelines.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
25 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • primiparas >25 years old
  • singleton pregnancy
  • Exclusion criteria:
  • prior diagnosed with diabetes

排除标准

  • 未提供

结局指标

主要结局

Glycated albumin reference interval in pregnancy

时间窗: gestational week 24-28

Glycated albumin will be analyzed by a new method based on mass spectrometry. Glycated albumin will be analyzed in blood samples taken during the OGTT.

次要结局

  • Induction of labour(At delivery)
  • Preeclampsia(From gestational week 20 until 1 week postpartum)
  • Birth weight(At delivery)
  • Oral glucose tolerance test in pregnancy(Gestational week 24-28)
  • HbA1c(Gestational week 24-28)
  • Iron status(Gestational week 24-28)
  • Glycaemic control(Gestational week 24-37)
  • APGAR(At delivery)
  • Admission to neonatal intensive care unit(At delivery)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Glycated Albumin in Pregnancy | 临床试验